Eur Rev Med Pharmacol Sci 2022; 26 (7): 2216-2216DOI: 10.26355/eurrev_202204_28446 Author Correction: Impact of sacubitril/valsartan on implantable defibrillator eligibility in heart failure: a real-world experience L. Monzo, C. Gaudio, F. Cicogna, C. Tota, V. Petronilli, S. Mennuni, E. De Ruvo, L. Calò Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (6): 1852-1859DOI: 10.26355/eurrev_202203_28330 The function of the ACE2/Ang(1-7)/Mas receptor axis of the renin-angiotensin system in myocardial ischemia reperfusion injury J.-X. Xie, J. Hu, J. Cheng, C. Liu, X. Wei Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (6): 1846-1851DOI: 10.26355/eurrev_202203_28329 Should coronary catheter laboratories be used in the treatment of ischemic stroke? Endovascular treatment in acute ischemic stroke performed by interventional cardiologists I. Kocayigit, H. Kilic, B.A. Acar, T. Acar, Y.G. Aras, Y. Can, H.A. Eryılmaz, S. Boncuk, R. Akdemir Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (6): 1839-1845DOI: 10.26355/eurrev_202203_28328 Effect of implantable cardioverter defibrillator implantation on frontal QRS-T angle F. Başyiğit, K.G. Balcı Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (6): 1789-1789DOI: 10.26355/eurrev_202203_28320 Methylprednisolone pulse therapy for relapsing polychondritis (RP) combined with heart block: myth or reality? M. Tang, Q.-P. Xie, K. Zhu, X.-L. Fu Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (5): 1492-1499DOI: 10.26355/eurrev_202203_28213 Left atrial functions in long term after catheter ablation of premature ventricular complexes A. Tutuncu, S. Kanat Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (4): 1101-1107DOI: 10.26355/eurrev_202202_28099 A novel intermediate coronary artery stenosis severity method: Fluoroscopy-Assisted Measurement of Coronary Volume Ratio (The FLAME FFR Trial) A. Tutuncu, S. Camci, A. Karakus, N. Bursa, M. Kinik, I. Zengin, K. Severgun, M. Demir, H. Ari Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (4): 1070-1072DOI: 10.26355/eurrev_202202_28094 Can the cardioprotective effect of microRNA-103 inhibitors be extended to women with polycystic ovary syndrome? P. Ramaswamy, M.K. Sibin, P. Misra, R. Sahu Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (4): 1068-1069DOI: 10.26355/eurrev_202202_28093 Comment on: Warfarin adherence and anticoagulation control in atrial fibrillation patients–a systematic review A. Caturano, V. Brunelli, R. Galiero, S. Spiezia, L. Rinaldi, F.C. Sasso Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (3): 759-770DOI: 10.26355/eurrev_202202_27984 Predicting no-reflow phenomenon prior to primary percutaneous coronary intervention using a novel probability risk score derived from clinical and angiographic parameters Z. Stajic, D. Milicevic, S. Kafedzic, A. Aleksic, M. Cerovic, M. Tasic, M. Andjelkovic Apostolovic, A. Ignjatovic, N. Zornic, G. Obradovic, V. Jovanovic, N. Jagic, A.N. Neskovic, G. Davidovic Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (3): 755-758DOI: 10.26355/eurrev_202202_27983 Antithrombotic therapy management in a man with ST elevation myocardial infarction and triple positive antiphospholipid syndrome: case report and literature review F.R. Prandi, M. Milite, R. Celotto, D. Lecis, M. Marchei, F. Romeo, F. Barillà Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (2): 440-447DOI: 10.26355/eurrev_202201_27868 Relationship between polymorphism rs2794521 in CRP gene and survival of depressive patients with chronic heart failure G. Opielak, T. Powrózek, A. Skwarek-Dziekanowska, G. Sobieszek, M. Rahnama-Hezavah, T. Małecka-Massalska Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (2): 432-439DOI: 10.26355/eurrev_202201_27867 MicroRNA-18-5p inhibits the oxidative stress and apoptosis of myocardium induced by hypoxia by targeting RUNX1 P. Li, X.-Y. Jia Free PDF Download
Eur Rev Med Pharmacol Sci 2022; 26 (2): 422-431DOI: 10.26355/eurrev_202201_27866 MiR-486 alleviates hypoxia/reoxygenation-induced H9c2 cell injury by regulating forkhead box D3 N. Wang, Y.-B. Yu Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7947-7963DOI: 10.26355/eurrev_202112_27645 Comparing heart risk scores to identify the most important risk factors for cardiovascular diseases R. Khandia, N. Puranik, N. Lodhi, B. Gautam, T. Alqahtani, A.M. Alqahtani, A.H. Alamri, K. Chidambaram Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7941-7946DOI: 10.26355/eurrev_202112_27644 Evaluation of heart rate recovery index in patients with coronary slow flow: preliminary results L. Askin Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7934-7940DOI: 10.26355/eurrev_202112_27643 The relationship between electrocardiographic findings and left ventricular apical thrombus E. Asoğlu, A. Afşin, A. Süner, H. Tibilli, N. Aladağ, R. Asoğlu Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7926-7933DOI: 10.26355/eurrev_202112_27642 Warfarin adherence and anticoagulation control in atrial fibrillation patients: a systematic review M. Ababneh, S.A. Nasser, A. Rababa’h, F. Ababneh Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (24): 7913-7925DOI: 10.26355/eurrev_202112_27641 The potential mechanism of PPP2R3A in myocardial cells and its interacting proteins C.-Y. Wu, Y. Liang, X.-F. Li, G.-B. Song Free PDF Download
Eur Rev Med Pharmacol Sci 2021; 25 (23): 7418-7424DOI: 10.26355/eurrev_202112_27439 The impact of percutaneous left atrial appendage closure on left ventricular diastolic function and natriuretic peptide levels C. Şabanoğlu, S. Okutucu, İ. Halil İnanç, H. Yorgun, K. Aytemir, A. Oto Free PDF Download